Tuval, Amos http://orcid.org/0000-0001-9330-4270
Strandgren, Charlotte http://orcid.org/0009-0002-3127-1578
Heldin, Angelos
Palomar-Siles, Mireia
Wiman, Klas G. http://orcid.org/0000-0002-7113-524X
Article History
Accepted: 23 November 2023
First Online: 15 December 2023
Competing interests
: K.G.W. has received research funding from, is a cofounder and shareholder of, and has previously received a salary from Aprea Therapeutics, a company that develops p53-based cancer therapies including eprenetapopt. The other authors declare no competing interests.